Abstract: Healthful supplements are described herein. For example, the supplements can include at least four of the following types of nutrients: an amino acid blend, a coconut extract, a vegetable glycerin extract, an alcohol blend, a cannabinoid blend, a hemp plant extract, a Boswellia serrata extract, a curcuma/turmeric blend, black cumin seed, an Artemisia ludoviciana extract, an Astragalus extract, a fenugreek extract, a mushroom extract blend, or any combination thereof.
Abstract: Compositions including herbal extracts, such as a Vitex negundo extract, a Cardiospermum halicacabum extract, and a Bambusa arundinacea extract, and methods using such compositions are disclosed. For example, compositions and methods may be used to improve joint health.
Abstract: The use of a lignin fraction as an anti-phytopathogenic agent, anti-phytopathogenic compositions comprising the same, as well as methods of protecting plants against phytopathogens, are disclosed.
Type:
Grant
Filed:
June 26, 2017
Date of Patent:
June 21, 2022
Assignees:
UPM-KYMMENE CORPORATION, GREEN INNOVATION GMBH
Inventors:
Suvi Pietarinen, Christian Hübsch, Giuliano Leonardi
Abstract: Disclosed are a method for preparing a hydroalcoholic extract obtained from a biomass of the shoots of a plant from the family of Plumbaginaceae, a butanol extract of Armenia maritima, a method for the preparation thereof, the use thereof, and compositions containing same.
Type:
Grant
Filed:
June 15, 2017
Date of Patent:
June 14, 2022
Assignees:
BIOTECHMARINE, SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, L'UNIVERSITE DE STRASBOURG
Abstract: The present invention relates to a composition comprising a mixed alcoholic extract of eighteen botanical ingredients formulated into capsules for the treatment of H1N1 flu, strep, pneumonia, and Covid-19.
Abstract: A medicinal composition includes an active herbal component that is prepared by cooking a combination of Sheng Di Huang, Da Huang and Jin Yin Hua and has an average particulate size between 100-300 nm. Example formulations include topical gels, tablets and capsules.
Type:
Grant
Filed:
March 27, 2017
Date of Patent:
May 31, 2022
Assignee:
Sirbal Limited
Inventors:
Nadav Shraibom, Eran Steinberg, Manu Jaggi, Anu T. Singh, Ritu Verma, Alka Madaan
Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
Abstract: Methods of treatment for atopic dermatitis in a human subject or animal, the methods comprising administering topically to the human subject or animal an active ingredient obtained from Ophiopogon japonicus.
Abstract: In various implementations, a skin therapeutic may be topically applied to improve skin health. The skin therapeutic may decrease inflammation, decrease redness, and/or decrease health times. The skin therapeutic may include a composition that includes two or more of Brassica olearacea italica Seed Oil, bisabolol, and/or Zingiber officinales.
Abstract: A formulation for solubilizing a water insoluble pharmaceutical agent is provided. The formulation comprises: a water-insoluble pharmaceutical agent, a detergent, an enzyme that breaks down lipids, proteins, and/or starches, a plasticizing agent, an emulsifying agent and an aqueous solvent. A method of making the formulation is also provided.
Abstract: A process is provided for improving the water solubility of cannabinoids by combining cannabinoids with fat globules obtained from animals, plants, or synthetic chemistry. The animals can be mammals or non-mammals. The plants can be whole plants, tissue cultures, or genetically engineered plants. The fat globules can be used in their natural environment, and/or following processing, and/or as separated or purified particles.
Abstract: The pesticide and method of manufacturing includes one component extracted from an evergreen Bush “Larrea tridentate” the common name of which is Gobernadora, in which the main active ingredient is nordihydroguaiaretic acid(NDGA) 1,4-Bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane, 4,4?-(2,3-Dimethyltetramethylene) dipyrocatechol. The composition of which is enriched with plant oils, emulsifiers and humidifiers, thus obtaining a product which can be easily used in crops with the help of sprinklers. Consequently, the action field of this procedure is within chemical compositions used to cultivate crops and fruit products.
Type:
Grant
Filed:
November 24, 2019
Date of Patent:
March 22, 2022
Assignee:
PROMOTORA TECNICA INDUSTRIAL, S.A. DE C.V.
Inventors:
Mario Saavedra Aguilar, Odon Vite Vallejo
Abstract: The invention relates to the field of polymer production, in particular to the production of chitin and chitosan from microalgae belonging to the phylum Haptophyta to the phylum Chlorophyta, or to the phylum Heterokontophyta, particularly from microalgae of the genus Isochrysis, Chlorella, Bracteacoccus, Chlorococcum, Scenedesmns, Desmodesmus, Haematococcus, Thalassiosira and Nannochloropsis, as well as to microalgal extracts thereof and their uses.
Type:
Grant
Filed:
December 16, 2015
Date of Patent:
March 22, 2022
Assignee:
Algaktiv, S.L.
Inventors:
Derek Georges Latil De Ros, María Teresa López Cerro, Eugenia Ruiz Canovas, Olga Durany Turk, Jordi Segura De Yebra, Jaume Mercadé Roca, Daniel Pérez Reyes, Xavier Álvarez Mico
Abstract: This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a Bacopa monnieri extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.
Type:
Grant
Filed:
November 21, 2018
Date of Patent:
March 15, 2022
Assignee:
Melaleuca, Inc.
Inventors:
Alexander B. Rabovsky, Stephanie Y. Nielson
Abstract: The present disclosure relates to methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses immune system deficiencies and promotes healthy immune system functioning. The present disclosure also related to compositions and methods for improving or boosting immune system functioning. The present disclosure further provides novel compositions for balancing immune response in human subjects.
Abstract: Compositions for reducing skin aging resulting from oxidative stress and/or photodamage are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
Type:
Grant
Filed:
April 30, 2014
Date of Patent:
March 1, 2022
Assignee:
Kimberly-Clark Worldwide, Inc.
Inventors:
Lucia Piccotti, David J. Tyrrell, Penkanok Sriwiriyanont, Debbie Ngai, Josh Gregorio, Scott W. Wenzel, Rebecca Uelmen, Seungjun ‘Jason’ Lee
Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.
Abstract: Exemplary embodiments provide oat fractions, and methods of producing the oat fractions, of the species Avena Sativa that has a concentration of total Avenanthramides that is from about 2 to about 25 wt. %, and up to about 30 wt. % or more, higher than the concentration before treatment with infrared energy. The higher concentration is achieved without treatment with enzymes or exposure to fungal agents to increase the concentration of total Avenanthramides. Instead, the enhanced concentration of Avenanthramides is achieved through exposure to infrared energy for a selected period of time.
Abstract: Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.